Who We Are

Aruvant Sciences is focused on developing and commercializing gene therapies for hematological diseases utilizing reduced-intensity conditioning. 

Therapeutic Focus

Sickle Cell Disease

Sickle cell disease is an autosomal recessive disease that causes red blood cells to have abnormal hemoglobin leading to distorted sickle-shaped cells, frequent infections and other complications. Sickle cells carry less oxygen, clump easily, clog capillaries, and cause chronic pain.  

Beta Thalassemia

Beta thalassemia is an inherited blood disorder that reduces the production of hemoglobin leading to anemia, pale skin, weakness, and fatigue amongst other complications.

Pipeline

Our Partners

//aruvant.com/wp-content/uploads/2018/11/Cincinnati_Childrens_Hospital_Medical_Center_Logo.png